Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.37 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | GALR3 | O60755 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | HRH1 | P35367 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL7710344 | 0.98 | TSHR (0.39) | TSHRKCNH2CHRM2CHRM4CHRM1 | |
| SCHEMBL9818650 | 0.87 | TDP1 (0.43) | TSHRKCNH2TDP1 | |
| SCHEMBL6517414 | 0.82 | TSHR (0.37) | TSHRKCNH2CHRM2CHRM4CHRM1 | |
| SCHEMBL25362541 | 0.81 | KCNH2 (0.31) | TSHRKCNH2USP2 | |
| SCHEMBL611932 | 0.79 | TSHR (0.39) | TSHRKCNH2CHRM2CHRM4CHRM1 | |
| SCHEMBL20001689 | 0.79 | CHRNB2 (0.39) | TSHRCHRM2CHRM4CHRM1LMNA | |
| SCHEMBL11549731 | 0.79 | CHRNB2 (0.39) | CHRM2CHRM4CHRM1 | |
| SCHEMBL7718350 | 0.79 | ALDH1A1 (0.32) | TSHRALDH1A1 | |
| SCHEMBL28669002 | 0.79 | ALDH1A1 (0.39) | TSHRLMNAALDH1A1 | |
| SCHEMBL137792 | 0.79 | TSHR (0.39) | TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3368089-A1 | NANOPARTICLE FORMULATIONS FOR DELIVERY OF NUCLEIC ACID COMPLEXES | TRANSLATE BIO MA, INC. (US) | 2018-09-05 | — | — | EP | claimed |
| WO-2017075038-A1 | NANOPARTICLE FORMULATIONS FOR DELIVERY OF NUCLEIC ACID COMPLEXES | RANA THERAPEUTICS, INC. (US) | 2017-05-04 | — | — | WO | claimed |
| EP-4735415-A1 | CALIXARENE COMPOUNDS, THEIR SYNTHESIS AND USE IN PHARMACEUTICAL COMPOSITIONS | Phoenix Biosciences SA (BE) | 2026-05-06 | — | — | EP | disclosed |
| WO-2025229369-A1 | SYNTHETIC NUCLEIC ACID MOLECULES AND USE THEREOF | 삼성바이오로직스 주식회사 | 2025-11-06 | — | — | WO | disclosed |
| US-12297432-B2 | Oligonucleotides for the treatment of nucleotide repeat expansion disorders associated with MSH3 activity | TAKEDA PHARMACEUTICALS U.S.A., INC. (US) | 2025-05-13 | — | — | US | disclosed |
| EP-4531902-A1 | NUCLEIC ACID BASED VACCINE ENCODING AN ESCHERICHIA COLI FIMH ANTIGENIC POLYPEPTIDE | CureVac SE (DE) | 2025-04-09 | — | — | EP | disclosed |
| WO-2025019903-A1 | RNA VACCINES FOR USE IN ANIMAL HEALTH | Denteric Pty Ltd (AU) | 2025-01-30 | — | — | WO | disclosed |
| WO-2024223953-A1 | CALIXARENE COMPOUNDS, THEIR SYNTHESIS AND USE IN PHARMACEUTICAL COMPOSITIONS | QUANTOOM BIOSCIENCES S.A. (BE) | 2024-10-31 | — | — | WO | disclosed |
| EP-4444885-A2 | IRNA COMPOSITIONS AND METHODS FOR SILENCING MYLIP | Alnylam Pharmaceuticals, Inc. (US) | 2024-10-16 | — | — | EP | disclosed |
| EP-4402261-A1 | IRNA COMPOSITIONS AND METHODS FOR SILENCING ANGPTL4 | Alnylam Pharmaceuticals, Inc. (US) | 2024-07-24 | — | — | EP | disclosed |
| WO-2024125597-A1 | COMPOSITIONS AND METHODS FOR INFECTIOUS DISEASES | PROVIDENCE THERAPEUTICS HOLDINGS INC. (CA) | 2024-06-20 | — | — | WO | disclosed |
| WO-2012027713-A2 | COMPOSITIONS AND METHODS FOR INHIBITION OF SNCA | ALNYLAM PHARMACEUTICALS, INC. (US) | 2012-03-01 | — | — | WO | disclosed |
| US-20120041134-A1 | CONJUGATED DIENE-BASED POLYMER, CONJUGATED DIENE-BASED POLYMER COMPOSITION, AND PROCESS FOR PRODUCING CONJUGATED DIENE-BASED POLYMER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-02-16 | — | — | US | disclosed |
| US-20110237737-A1 | CONJUGATED DIENE POLYMER RUBBER, AND CONJUGATED DIENE POLYMER RUBBER COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-09-29 | — | — | US | disclosed |
| WO-2011108955-A1 | MULTI -TARGETING SYSTEM COMPRISING A NANOCARRIER, NUCLEIC ACID(S) AND NON-NUCLEIC ACID BASED DRUG(S) | UNIVERSIDADE DE COIMBRA (PT) | 2011-09-09 | — | — | WO | disclosed |
| EP-2344639-A2 | COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF TRANSTHYRETIN | Alnylam Pharmaceuticals, Inc. (US) | 2011-07-20 | — | — | EP | disclosed |
| EP-2250266-A2 | COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF CD45 GENE | Alnylam Pharmaceuticals Inc. (US) | 2010-11-17 | — | — | EP | disclosed |
| WO-2010048228-A2 | COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF TRANSTHYRETIN | ALNYLAM PHARMACEUTICALS, INC. (US) | 2010-04-29 | — | — | WO | disclosed |
| WO-2009137128-A2 | COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF CD45 GENE | ALNYLAM PHARMACEUTICALS, INC. (US) | 2009-11-12 | — | — | WO | disclosed |
| US-6201093-B1 | MERCAPTO-FUNCTIONAL POLYSILOXANES MODIFIED WITH ETHENICALLY UNSATURATED COMPOUNDS CONTAINING AMINO GROUPS; USE AS TEXTILE FINISHING AIDS, SURFACTANTS AND EMULSIFIERS | HUELS AKTIENGESELLSCHAFT (DE) | 2001-03-13 | — | — | US | disclosed |